Maria Assunta Giocon Oca
Internal Medicine · Jackson Heights, NYNPI 1609077049
Payments from drug & device makers
Across 149 payments — averaging $19.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$974
- Merck$382
- AbbVie$364
- Lilly USA, LLC$347
- GSK$261
- Boehringer Ingelheim$159
- plus $387 from 10 others
What the payments were for
- Food & beverage$2,874100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $974 |
| Merck | 21 | $382 |
| AbbVie(2 entities) | 18 | $364 |
| Lilly USA, LLC | 16 | $347 |
| GSK | 12 | $261 |
| Boehringer Ingelheim | 8 | $159 |
| Amarin Pharma, Inc. | 5 | $96 |
| Novo Nordisk | 3 | $61 |
| Renalytix AI, Inc. | 2 | $46 |
| Pfizer | 2 | $39 |
| Cumberland Pharmaceuticals, Inc. | 3 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Redhill Biopharma Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
How this compares
$2,874 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 28 | $35,527 |
| JanuviaSitagliptin Phosphate | 22 | $14,890 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $9,301 |
| FarxigaDapagliflozin Propanediol | 11 | $5,726 |
| Diclofenac Sodium | 143 | $2,508 |
| Fenofibrate | 39 | $1,190 |
| Fluocinonide | 16 | $1,172 |
| Ammonium Lactate | 38 | $1,109 |
| Levothyroxine Sodium | 74 | $1,078 |
| Irbesartan | 39 | $1,006 |
| Rosuvastatin Calcium | 78 | $830 |
| Famotidine | 56 | $826 |
| Omeprazole | 46 | $646 |
| Atorvastatin Calcium | 70 | $636 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 31 | $622 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $159 | $35,52728 claims |
| MerckJanuvia, Janumet | $382 | $24,19134 claims |
| AstraZenecaFarxiga | $974 | $5,72611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Jackson Heights
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.